Pulmonary Rehabilitation, Dyspnoea and Emotional Cognition in COPD

COPD Clinical Trial

— READ-COG BPCO  

Official title:

Effects of Pulmonary Rehabilitation on Dyspnoea Affective Dimension and Emotional Cognition in Patients With Chronic Obstructive Pulmonary Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03092700
• Other study ID #: 2017-A00045-48
• Status: Completed
• Start date: April 5, 2017
• Est. completion date: August 16, 2017

Study information

• Verified date: February 2021
• Source: Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To evaluate whether pulmonary rehabilitation improves emotional cognition, using facial emotions recognition and smile production, by improving the emotional dimension of dyspnoea in patients with chronic obstructive pulmonary disease (COPD).To evaluate whether pulmonary rehabilitation improves emotional cognition, using facial emotions recognition and smile production, by improving the emotional dimension of dyspnoea in patients with chronic obstructive pulmonary disease (COPD).

Description:

The aim of the study will be to evaluate the effect of pulmonary rehabilitation on dyspnoea emotional component and on emotional cognition. It will add a better understanding of the mechanisms of pulmonary rehabilitation on dyspnoea.

Patients with COPD will be included before starting a pulmonary rehabilitation and be evaluated with questionnaires (including the Multidimensional Dyspnea Profile, and quality of life questionnaires), emotional cognition (at rest and right after an endurance test, using some short movies sequences and pictures of faces expressing some well defined emotions) and smile production analysis.

After having followed a pulmonary rehabilitation, the same evaluation will be realised and results will be compared before and after the intervention.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: August 16, 2017
• Est. primary completion date: August 16, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 90 Years

Eligibility

Inclusion Criteria:

• COPD patients with pulmonary rehabilitation indication, hospitalized in Department of Pulmonary Diseases in La Pitié-Salpêtrière, Paris, France.

• Age of 40 at least.

Exclusion Criteria:

• Facial paralysis

• Neuromuscular disease

• Contraindication for pulmonary rehabilitation

• Severe depression syndrom or psychiatric disease

• Drug use

• Impaired vision

• Higher functions disorders (Mini Mental Score Examination < 26)

• Severe obesity (BMI>40kg/m²)

Related Conditions & MeSH terms

• Affective Symptoms
• COPD
• Dyspnea
• Emotional Disturbances
• Rehabilitation; Tobacco Use

Locations

Country	Name	City	State
France	Centre d'Investigation Clinique Paris Est, Groupe Hospitalier Pitié-Salpêtrière	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	emotional cognition	Emotional cognition in patients with chronic dyspnoea using time to recognize some emotions on short movies and pictures of facial emotions.	6 weeks
Secondary	Correlation between physical improvement, quality of life improvement and time to recognize facial emotions.	Correlations	6 weeks
Secondary	Correlations between physical improvement and production of the smile.	Correlations	6 weeks